Search
Video
UCSF Thoracic Surgery Leaders Discuss Diagnostic and Surgical Innovations to Treat Lung Cancer and Lung Diseases
Robotic-assisted surgery at UCSF allows thoracic surgeons to perform intricate procedures with a high level of precision and dexterity, providing optimal patient outcomes.
News
How Targeting Aging Cells Could Improve Lung Disease Treatment
UCSF Researchers Identify Drug Pipeline to Attack Aging Cells in Diseased Lung Tissue.
News
UCSF Health Reaches Lung Transplant Milestone
Surgeons at the UCSF Lung Transplant program have performed over 100 transplants in a 12-month period, making it one of a handful of medical centers in the nation to reach that milestone.
News
Improving Clinical Outcomes for Venous Thromboembolism
Venous thromboembolism (VTE) is serious condition that begins with a blood clot in a vein – often in the lower leg – that makes its way to the lungs, causing a pulmonary embolism with potentially fatal consequences.
Video
Unconscious Bias in Patient Care: Harms and Paths to Healing
While physicians intend to treat all their patients with equal respect and compassion, studies show that favoritism and other implicit attitudes can emerge, especially in times of stress, affecting medical decisions and care quality.
Video
Better Management of Lung Nodules: Cutting-Edge Diagnostic and Therapeutic Tools
Interventional pulmonologist Diana H. Yu, MD – who performed the first robotic bronchoscopy at UCSF – presents the case for more aggressive lung screening in California and throughout the country, then offers an exciting look at the latest ultrasound and robotic techniques for detecting lesions, assessing risk of malignancy and performing biopsies.
News
Millions of Long-Term Smokers Have Lung Disease that Defies Diagnosis
Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria – including the most common of those, chronic obstructive pulmonary disease (COPD)...
News
Deadly Dust: Engineered Stone Is Making California Workers Sick
Workers making artificial-stone slabs for the most popular type of countertops sold in the United States are developing a potentially deadly, irreversible lung disease from tiny particles of toxic dust, researchers from UC San Francisco and UCLA found...
News
Can Reducing Insulin Resistance Minimize Severe Asthma Symptoms?
UCSF researchers led a study that found insulin resistance (IR) is common in patients with severe asthma and is associated with lung function impairment and suboptimal responses to asthma medications.
News
UCSF’s First Medical Director of Robotic Surgery on Improving Patient Outcomes and Enabling Innovation
Thoracic surgeon Johannes Kratz, MD, has been selected as UCSF’s first medical director of robotic surgery.
News
New ATS Recommendation: Use Race-Neutral Equations for Pulmonary Function Test Interpretation to Improve Patient Care
An American Thoracic Society (ATS) workshop committee, which included many UCSF researchers, recently released an official statement recommending the use of race-neutral average reference equations for pulmonary function test (PFT) interpretation.
News
Susceptibility to Pathogenic T Cells in Chronic Lung Disease May have a Genetic Basis
Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue, and leading to one of the most common diagnoses for hospital admissions.
News
Some Patients with Lung Disease Fare Worse Than Others. Could Sleep Explain It?
Flare-Ups in COPD Linked to Sleeplessness, UCSF-Led Study Shows
Document
UCSF Lung Transplant Clinic in Roseville
UCSF Lung Transplant Clinic in Roseville
News
Race-Based Equations May Lead to Under-Treatment of Lung Disease in Black Patients
Using race-based equations to evaluate lung disease -- a practice promoted in the 2019 guidelines of the American Thoracic Society -- may mean that severe lung disease in Black patients is classified as moderate disease, according to a UCSF-led study.
Video
Lung Transplant Candidates: Shining a Light on UCSF’s Evaluation Process
In this short presentation, pulmonologist Jeffrey A. Golden, MD, describes how the specialists of the UCSF Lung Transplant Program work together to ensure their patients are likely to succeed, with a focus on factors that can make or break survival prospects.
News
Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.
Video
The COPD Blues: A Guide to Optimizing Outpatient Management
For the 30 million adults in the U.S. with COPD, effective care requires providers to have an up-to-date understanding of treatment options as well as the ability to respond to changes in a patient’s status.
News
New Research on Cell Regeneration Shows Promise for Treating Lung Injury and Fibrosis
In a new study, UCSF researchers showed that they could successfully redirect profibrotic murine lung cells to a nonfibrotic state in which they regenerated alveoli. These findings could lead to novel treatments for lung injury and fibrosis.
News
UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life
Hospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years Later
News
UCSF-led Study Uncovers Unique Stem Cell Trajectory in Lungs Damaged by COVID-19 and Pulmonary Fibrosis
In a collaborative study between UCSF researchers appearing December 30 in Nature Cell Biology, UCSF researchers Jaymin Kathiriya, PhD, and Chaoqun Wang, PhD, discovered that severe lung injuries can trigger lung stem cells to undergo abnormal differentiation. Drs. Kathiriya and Wang, supervised by Hal Chapman, MD, and Tien Peng, MD, respectively, utilized stem cell organoid models to uncover a novel stem cell pathway that is seen in severely injured lungs from COVID-19 and idiopathic pulmonary fibrosis patients.
News
Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.
News
UCSF Post-COVID Clinic Treats Long Haulers
UC San Francisco’s OPTIMAL Clinic (pOst-covid-19/PosT-Icu MultidisciplinAry cLinic) is one of the first clinics in the country established to provide follow-up care for patients who have recovered from COVID-19. The clinic’s goal is to optimize patient recovery through a centralized resource designed to coordinate with primary care services.
News
Lung Transplant Outcomes at UCSF Among the Nation’s Best
For nine consecutive years, the UCSan FranciscoLung Transplant Program has achieved significantly higher-than-expected survival rates following transplant surgery. It is the only lung transplant program in the country with this record.
